CA-XSOLLA
5.3.2024 14:01:29 CET | Business Wire | Press release
Xsolla, a global video game commerce company, has introduced Cross-Play and Cross-Pay, an innovative approach to mobile game monetization. In response to the evolving landscape, Xsolla’s suite of solutions enables mobile game developers to seamlessly transition their games from mobile to the web, desktop, and cloud while offering diverse monetization models out-of-the-box to power profitable direct-to-consumer sales for game developers.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240305100421/en/
(Graphic: Xsolla)
As the video game industry evolves, players anticipate engaging with their favorite titles seamlessly across all platforms, form factors, and control methods. This growing expectation places Cross-Play at the forefront of modern game development strategies. Mobile game developers can now effortlessly deploy their games across Mobile, PC, Console, Cloud, and Web with Xsolla Launcher and Xsolla Cloud Gaming.
Xsolla Launcher makes it easier for developers to leverage the capabilities of desktop computing, including enhanced graphics, gameplay depth, and longer play sessions when porting mobile games to PC.
Cloud Gaming for Mobile Games, in turn, is a strategic extension of the core Xsolla Cloud Gaming solution. It enables mobile video game developers to expand cross-platform by deploying game builds to cloud platforms directly from the developer's own branded landing page, allowing them to deliver flexible monetization mechanics for mobile users.
Cross-Play experience ensures consistent and fair monetization strategy across all platforms for developers around the world. This approach ensures equal access to game content for players, thereby enhancing the overall playing experience while adhering to platform rules and guidelines. Xsolla Web Shop, a leading solution for web purchases, is a foundation for the Direct-to-Consumer strategy for mobile game developers.
Web Shops are easily customizable branded online stores fully equipped to facilitate in-game web purchases. The next iteration of the Xsolla Web Shop Solution includes innovative updates drawing on Xsolla's expertise gained from launching over 210 Web Shops and 40 of the top 100 highest-grossing mobile games worldwide. Xsolla Web Shop introduces advanced LiveOps tools, additional personalization and engagement features, and an improved user flow for seamless purchases. Alongside these enhancements, Xsolla's experts are always available to offer guidance and support by providing best practices consultation in navigating the operation and management of web shops.
“The advancements made with Cross-Play Cross-Pay have been a focus of our innovation over the past year after collaborating with numerous partners and launching over 200 web shops in 2023. This extensive real-world application with customer feedback has helped mobile game developers to efficiently market their games online by operating within the platform guidelines,” said David Stelzer, President of Xsolla. “Cross-Play Cross-Pay is our strategic innovation to meet the continuously evolving demands of the ever-changing mobile game industry. By delivering a multi-platform solution for mobile game developers, we can help them to reach more players and to grow their business.”
This comprehensive suite of Cross-Play Cross-Pay solutions empowers mobile developers to ensure their games reach the widest possible audience by establishing deep and lasting connections with players around the globe.
For more information about Xsolla Web Shop 2.0 and its features, please visit: xsolla.pro/web-shop2
For more information about Xsolla Cloud Gaming for mobile and its features, please visit: xsolla.pro/cloud-gaming
For more information about Xsolla Launcher, please visit: xsolla.pro/xsolla-launcher
About Xsolla
Xsolla is a global video game commerce company with a robust and powerful set of tools and services designed specifically for the industry. Since its founding in 2005, Xsolla has helped thousands of game developers and publishers of all sizes fund, market, launch and monetize their games globally and across multiple platforms. As an innovative leader in game commerce, Xsolla’s mission is to solve the inherent complexities of global distribution, marketing, and monetization to help our partners reach more geographies, generate more revenue, and create relationships with gamers worldwide. Headquartered and incorporated in Los Angeles, California, with offices in London, Berlin, Seoul, Beijing, Kuala Lumpur, Raleigh, Tokyo, and cities around the world, Xsolla supports major gaming titles like Valve, Twitch, Roblox, Epic Games, Take-Two, KRAFTON, Nexters, NetEase, Playstudios, Playrix, miHoYo, and more.
For additional information and to learn more, please visit: xsolla.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240305100421/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte’s Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi®/Minjuvi®) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or Death by 25% in Patients with Previously Untreated, High-risk DLBCL30.5.2026 14:00:00 CEST | Press release
The Phase 3 frontMIND study evaluated tafasitamab (Monjuvi®/Minjuvi®) and lenalidomide in addition to R-CHOP, the current standard of care, compared with R-CHOP alone in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL)Positive trends toward progression-free survival (PFS) benefit with tafasitamab and lenalidomide plus R-CHOP (Tafa-Len-R-CHOP) were observed acrossprespecified subgroups, including in patients with centrally confirmed lymphoma subtypes and both cell-of-origin (COO) molecular subtypesThe frontMIND data support the submission of global regulatory applications for tafasitamab and lenalidomide added to R-CHOP for previously untreated DLBCLThe data are being presented in an oral session at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting and simultaneously published in The Lancet* Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating t
Fortegra Completes Acquisition by DB Insurance29.5.2026 22:30:00 CEST | Press release
The Fortegra Group, Inc. ("Fortegra"), a global specialty insurance company, today announced the completion of its acquisition by DB Insurance Co., Ltd. ("DB"), one of Korea's leading property and casualty insurers. The transaction, announced on September 26, 2025, received all required regulatory and stockholder approvals. Fortegra will operate independently, maintaining its existing leadership team, distribution relationships, and underwriting discipline. Agents, distribution partners, and customers will continue to experience the service excellence that has defined the Fortegra experience. Richard Kahlbaugh, Chairman and CEO of Fortegra, said: "Every company eventually changes ownership. That is the nature of business. The closing of this acquisition is a starting point. As part of DB Insurance, Fortegra is positioned to expand our business geographically, enhance our capabilities and deepen our market presence in the US, Europe, the United Kingdom and Asia. Together, DB Insurance a
SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report29.5.2026 22:01:00 CEST | Press release
Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the “Notification Letter”), from Nasdaq Listing Qualifications (“Nasdaq”) stating that as of May 8, 2026, the Company had regained compliance with the periodic filing and interim financial requirements in Nasdaq Listing Rules 5250(c)(1) (the “Periodic Filing Rule”) and 5250(c)(2), as required by the Panel’s decision dated January 21, 2026. As previously disclosed on January 22, 2026, under the Panel’s decision, SINOVAC was required to, on or before May 11, 2026, demonstrate compliance with such Nasdaq Listing Rules by completing filings of its annual report for the year ended December 31, 2024, on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of 2025 on Form 6-K. The Company timely completed such filings as required by the Panel’s decision.
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom